At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
In Brief
A Phase 4 clinical trial evaluating Written education material (basic), Additional education material, and 2 other interventions for Chronic Obstructive Pulmonary Disease (COPD). Completed, enrolled 444 participants across 6 sites.
Detailed Summary
About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).
Study Details
Timeline
Interventions
Education material on COPD distributed to all participants.
Additional education material sent to participants in the proactive and reactive arms.
In the proactive arm, calls will be initiated by the coach. The phone calls will involve educational and social support components. PELICAN is grounded on the social cognitive theory of behavior change and seeks to improve patient adherence by addressing patient self-efficacy and outcome expectancy.
Participants allocated to the reactive PELICAN group will be offered the opportunity to access the COPD Foundation Infoline toll-free.